Publications

Found 10 results
Filters: Keyword is Apolipoproteins E  [Clear All Filters]
2013
Yu E, Calvert PA, Mercer JR, Harrison J, Baker L, Figg NL, Kumar S, Wang JC, Hurst LA, Obaid DR, Logan A, West NEJ, Clarke MCH, Vidal-Puig A, Murphy MP & Bennett MR (2013) Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation 128, 702-12
2012
Mercer JR, Yu E, Figg N, Cheng K-K, Prime TA, Griffin JL, Masoodi M, Vidal-Puig A, Murphy MP & Bennett MR (2012) The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Free Radic Biol Med 52, 841-9
2010
Mercer JR, Cheng K-K, Figg N, Gorenne I, Mahmoudi M, Griffin J, Vidal-Puig A, Logan A, Murphy MP & Bennett M (2010) DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 107, 1021-31
2009
Ward H, Mitrou PN, Bowman R, Luben R, Wareham NJ, Khaw K-T & Bingham S (2009) APOE genotype, lipids, and coronary heart disease risk: a prospective population study. Arch Intern Med 169, 1424-9
Surtees PG, Wainwright NWJ, Bowman R, Luben RN, Wareham NJ, Khaw K-T & Bingham SA (2009) No association between APOE and major depressive disorder in a community sample of 17,507 adults. J Psychiatr Res 43, 843-7
2007
Wu K, Bowman R, Welch AA, Luben RN, Wareham N, Khaw K-T & Bingham SA (2007) Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J 28, 2930-6
2003
Watson MA, Gay L, Stebbings WSL, Speakman CTM, Bingham SA & Loktionov A (2003) Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis. Clin Sci (Lond) 104, 537-45
Yu-Wai-Man P, Morris CM, Zeviani M, Carrara F, Turnbull DM & Chinnery PF (2003) The role of APOE in the phenotypic expression of Leber hereditary optic neuropathy. J Med Genet 40, e41